Archer Investment Corp - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Archer Investment Corp ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,200
+5.9%
1,0000.0%0.01%0.0%
Q2 2023$36,070
-5.6%
1,0000.0%0.01%
-7.1%
Q1 2023$38,190
-32.9%
1,0000.0%0.01%
-36.4%
Q4 2022$56,900
-99.9%
1,0000.0%0.02%
+29.4%
Q3 2022$39,540,000
-10.1%
1,0000.0%0.02%
-5.6%
Q2 2022$44,000,000
+6.3%
1,0000.0%0.02%
+20.0%
Q1 2022$41,380,000
+2.9%
1,0000.0%0.02%
+7.1%
Q4 2021$40,210,000
-1.2%
1,0000.0%0.01%
-6.7%
Q3 2021$40,680,000
-10.4%
1,0000.0%0.02%
-16.7%
Q2 2021$45,410,000
+8.9%
1,0000.0%0.02%
+5.9%
Q1 2021$41,690,000
-2.4%
1,0000.0%0.02%
-15.0%
Q4 2020$42,710,000
+62.5%
1,0000.0%0.02%
+42.9%
Q3 2020$26,280,000
-2.0%
1,0000.0%0.01%
-6.7%
Q2 2020$26,810,000
+148844.4%
1,0000.0%0.02%
+25.0%
Q1 2020$18,0000.0%1,0000.0%0.01%
+20.0%
Q4 2019$18,000
+12.5%
1,0000.0%0.01%0.0%
Q3 2019$16,000
-5.9%
1,0000.0%0.01%
-9.1%
Q2 2019$17,000
+6.2%
1,0000.0%0.01%0.0%
Q1 2019$16,000
+6.7%
1,0000.0%0.01%
-15.4%
Q4 2018$15,0001,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders